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Abstract
Background  and  objectives:  Current  guidelines  for  neuraxial  analgesia  in  patients  with  multiple
sclerosis are  ambiguous  and  offer  the  clinician  only  a  limited  basis  for  decision  making.  This  sys-
tematic review  examines  the  number  of  cases  in  which  multiple  sclerosis  has  been  exacerbated
after central  neuraxial  analgesia  in  order  to  rationally  evaluate  the  safety  of  these  procedures.
Methods: A  systematic  literature  search  with  the  keywords  ‘‘anesthesia  or  analgesia’’  and
‘‘epidural, peridural,  caudal,  spinal,  subarachnoid  or  intrathecal’’  in  combination  with
‘‘multiple  sclerosis’’  was  performed  in  the  databases  PubMed  and  EMBASE,  looking  for  clinical
data on  the  effect  of  central  neuraxial  analgesia  on  the  course  of  multiple  sclerosis.
Results and  conclusions:  Over  a  period  of  65  years,  our  search  resulted  in  37  reports  with  a
total of  231  patients.  In  10  patients  multiple  sclerosis  was  worsened  and  nine  multiple  sclerosis
or neuromyelitis  optica  was  ﬁrst  diagnosed  in  a  timely  context  with  central  neuraxial  analgesia.
None of  the  cases  showed  a  clear  relation  between  cause  and  effect.  Current  clinical  evidence
does not  support  the  theory  that  central  neuraxial  analgesia  negatively  affects  the  course  of
multiple sclerosis.
©  2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).PALAVRAS-CHAVE Anestesia  neuraxial  em  pacientes  com  esclerose  múltipla  --  uma  revisão  sistemática
s  diretrizes  atuais  para  analgesia  neuraxial  em  pacientes  com  escle-
guas  e  oferecem  ao  clínico  apenas  uma  base  limitada  para  a  tomada
temática  examina  o  número  de  casos  nos  quais  a  EM  foi  exacerbadaEsclerose  múltipla;
Neuromielite  óptica;
Anestesia  neuroaxial
Resumo
Justiﬁcativa  e  objetivos:  A
rose múltipla  (EM)  são  ambí
de decisão.  Esta  revisão  sisPlease  cite  this  article  in  press  as:  Bornemann-Cimenti  H,  et  al.  Neuraxial  anesthesia  in  patients  with  multiple  sclerosis
--  a  systematic  review.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016.09.001
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BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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após  analgesia  neuraxial  central  para  avaliar  racionalmente  a  seguranc¸a desses  procedimentos.
Métodos:  Uma  busca  sistemática  da  literatura  usando  as  palavras-chave  ‘‘anestesia  ou  anal-
gesia’’ e  ‘‘epidural,  peridural,  caudal,  espinhal,  subaracnoideo  ou  intratecal’’  em  combinac¸ão
com ‘‘multiple  sclerosis’’  foi  realizada  nas  bases  de  dados  PubMed  e  EMBASE  à  procura  de  dados
clínicos  sobre  a  efeito  da  analgesia  neuraxial  central  sobre  o  curso  da  esclerose  múltipla.
Resultados  e  conclusões: Durante  um  período  de  65  anos,  nossa  busca  resultou  em  37  relatos
com um  total  de  231  pacientes.  Em  10  pacientes,  a  esclerose  múltipla  foi  agravada  e,  em  nove
pacientes, a  esclerose  múltipla  ou  neuromielite  óptica  foi  diagnosticada  pela  primeira  vez  em
momento concomitante  com  a  analgesia  neuraxial  central.  Nenhum  dos  casos  apresentou  uma
clara relac¸ão  entre  causa  e  efeito.  A  evidência  clínica  atual  não  sustenta  a  teoria  de  que  a
analgesia neuraxial  central  afeta  negativamente  o  curso  da  esclerose  múltipla.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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ultiple  sclerosis  (MS)  is  a  chronic  autoimmune  condition
f  the  central  nervous  system  (CNS),  with  diffuse  and  focal
reas  of  inﬂammation,  demyelination,  gliosis,  and  neuronal
njury.  The  exact  mechanisms  behind  this  disease  are  not
ompletely  understood,  but  current  concepts  suggest  a  com-
lex  multifactorial  genesis  with  genetic,  environmental,
mmunological,  and  microbiological  factors.1
In  1949,  Fleiss  reported  the  appearance  of  MS  after
pinal  anesthesia,2 and  this  led  to  the  speculation  that
ntrathecal  application  of  local  anesthetics  could  precipi-
ate  or  exacerbate  this  disease.3 As  a  consequence,  central
euraxial  analgesia  was  regarded  to  be  relatively  con-
raindicated  in  MS.4,5 Direct  toxicity  of  local  anesthetics
as  discussed  as  potentially  harmful  as  was  mechanical
rauma  or  neural  ischemia  secondary  to  local  anesthetics
r  additives.  Oligopeptides  with  Na-channel  blocking  activ-
ties  have  recently  been  found  in  cerebrospinal  ﬂuid  of
atients  suffering  from  MS,  leading  to  the  assumption  of
ncreased  vulnerability  to  local  anesthetics.6 Despite  many
onsiderations,  no  commonly  accepted  theory  exists  on
he  particular  mechanisms  of  how  neuraxial  analgesia  may
lter  the  course  of  MS;  it  also  remains  unclear  if  neurax-
al  techniques  are  actually  harmful.  Nevertheless,  several
nesthesiologists  still  fear  the  possible  exacerbation  of  pre-
xisting  deﬁcits  and  are  reluctant  to  offer  spinal  or  epidural
nalgesia  to  patients  with  MS.7
Current  guidelines  for  central  neuraxial  analgesia  in
atients  with  MS  are  ambiguous  and  offer  the  clinician  only
 limited  basis  for  decision-making.  The  American  Society
f  Regional  Anesthesia  and  Pain  Medicine  (ASRA)  states  in
ts  2008  practice  advisory  that  ‘‘the  existing  literature  nei-
her  conﬁrms  nor  refutes  the  safety  of  neuraxial  anesthesia
n  patients  with  CNS  or  peripheral  nervous  system  neuro-
ogic  disorders,  nor  does  it  deﬁnitively  address  the  relative
afety  of  spinal  vs.  epidural  anesthesia  (EA)  or  analgesia  in
hese  patients’’.8 A  consensus  statement  from  2014  recom-Please  cite  this  article  in  press  as:  Bornemann-Cimenti  H,  et  a
--  a  systematic  review.  Rev  Bras  Anestesiol.  2016.  http://dx.do
ends  that  the  indication  of  spinal  anesthesia  in  pregnant
atients  with  MS  should  be  discussed  on  a  case-by-case
asis.9
T
IIn  the  absence  of  sufﬁcient  high-level,  large-scale,
rospective  studies,  all  these  guidelines  refer  to  cases  of
eterioration  of  MS  after  neuraxial  anesthesia.  However,
ntil  now  the  exact  number  of  reported  cases  has  not  yet
een  investigated.  This  systematic  review  aims  to  determine
he  number  of  cases  in  which  MS  has  been  exacerbated  after
entral  neuraxial  analgesia  in  order  to  rationally  evaluate
he  safety  of  these  procedures.
ethods
 systematic  literature  search  for  articles  reporting  on  the
linical  course  of  MS  after  epidural,  spinal,  combined  spinal
nd  epidural  or  caudal  analgesia  in  human  subjects  was
arried  out  using  the  databases  PubMed  and  EMBASE.  We
ncluded  all  kinds  of  articles  providing  clinical  data,  espe-
ially  case-series  or  case-reports.  The  search  term  included
he  keywords  ‘‘anesthesia  or  analgesia’’  and  ‘‘epidural,
eridural,  caudal,  spinal,  subarachnoid  or  intrathecal’’
n  combination  with  ‘‘multiple  sclerosis.’’  Language  was
estricted  to  English,  German,  French,  Spanish  and  Por-
uguese.  The  Cochrane  database  and  the  clinicaltrials.gov
tudy  registry  were  searched  to  identify  further  ongoing
r  planned  trials.  As  the  distinction  between  neuromyeli-
is  optica  and  MS  was  unclear  until  a  few  years  ago,10 we
ecided  to  include  cases  about  both  diseases.
Title,  abstract,  and  full-text  screenings  were  conducted
onsecutively  by  two  independent  reviewers  (HBC  and
T).  If  diverging  appraisal  of  literature  occurred,  a  third
eviewer  decided  how  to  proceed.  References  of  articles  and
eviews  were  screened  further  for  additional  publications
hat  were  not  detected  by  our  primary  literature  search.
he  manuscript  was  prepared  according  to  the  PRISMA  state-
ent  (Preferred  Reporting  Items  for  Systematic  Reviews  and
eta-Analyses).11l.  Neuraxial  anesthesia  in  patients  with  multiple  sclerosis
i.org/10.1016/j.bjane.2016.09.001
he  last  literature  search  was  conducted  in  May  2015.
n  total,  248  primary  hits  were  identiﬁed.  Thirty-seven
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Embase and pubmed search
(anesthesia OR analgesia) AND (epidural OR peridural OR caudal OR spinal
OR subarachnoid OR intrathecal) AND “multiple sclerosis”.
248 primary hits
Title screening
79 publications
remaining
Abstract
screening
53 publications
remaining
Full-text
screening
35 relevant
publications
6 publications
from further
sources included
11 studies and
case series 26 case reports
22 publications
excluded
26 publications
excluded
169 publications
excluded
Figure  1  Flowchart.
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apublications  were  selected  by  title,  abstract,  and  full-text-
screening,  including  11  studies  and  26  case  reports  (Fig.  1,
Tables  1  and  2).
A  total  of  243  interventions  in  231  patients  were
included.  EA  was  used  in  180  cases,  spinal  analgesia  in
59,  caudal  analgesia  in  three,  and  Combined  Spinal  and
Epidural  (CSE)  once.  In  10  patients,  a  deterioration  of
MS  was  observed  in  context  with  central  neuraxial  anal-
gesia  (three  spinals,  seven  EAs).  In  six  cases,  MS  was
ﬁrst  diagnosed  after  spinal  anesthesia,  and  in  three  casesPlease  cite  this  article  in  press  as:  Bornemann-Cimenti  H,  et  a
--  a  systematic  review.  Rev  Bras  Anestesiol.  2016.  http://dx.do
neuromyelitis  optica,  a  demyelinating  disease  that  shares
many  similarities  with  MS,  was  ﬁrst  diagnosed  after  spinal
analgesia.  In  two  cases,  symptoms  of  MS  improved  after
EA.
c
t
o
liscussion
n  clinical  practice,  the  patient  with  MS  is  a  rare  event.
ost  anesthesiologists  encounter  less  than  one  of  these
atients  per  year,7 and  therefore,  experience  in  periop-
rative  management  is  often  limited.  General  anesthesia
s  most  frequently  used  in  this  population  and  generally
egarded  as  safe.12,13 On  the  other  hand,  neuraxial  analgesia
n  patients  with  MS  remains  controversial.  As  guidelines  are
mbiguous  or  recommend  a case-by-case  decision,8,9 theirl.  Neuraxial  anesthesia  in  patients  with  multiple  sclerosis
i.org/10.1016/j.bjane.2016.09.001
linical  applicability  is  limited.  The  question,  if  neuraxial
echniques  are  safe  in  patients  suffering  from  MS,  has  not
nly  a  medical  but  also  a juridical  dimension.  In  a  recent
egal  case  in  Italy,  the  development  of  optical  neuritis  was
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Table  1  Case  reports  of  patients  with  multiple  sclerosis  undergoing  neuroaxial  analgesia.
Author
(reference)
Patients
characteristics
Type  of
anesthesia
Type  of  surgery  Complication  Details
Fleiss2 36  years,  male  Spinal  Orthopedic  Yes  Multiple  sclerosis  ﬁrst
diagnosed  after  spinal
anesthesia
Warren24 21  years,  female  EA  Vaginal  delivery,
CS
Yes  Hypesthesia  on  the  thigh,
restitution  after  7  days  (1◦
delivery)  and  7  weeks  (2◦
delivery)
Levesque25 33  years,  female  Spinal  Plastic  surgery  Yes  Multiple  sclerosis  ﬁrst
diagnosed  after  spinal
anesthesia
Hosseini26 23  years,  female  Spinal  Hallux  valgus  Yes  Neuromyelitis  optica  ﬁrst
diagnosed  after  spinal
anesthesia
Lopez
Ariztegui27
32  years,  female  EA  Vaginal  delivery  Yes  Acute  transverse  disorder  ﬁrst
diagnosed  two  weeks  after  PDA
Facco14 34  years,  female  Spinal  CS  Yes  Neuromyelitis  optica  6  months
after  spinal;  conus  medullaris
lesion  while  puncturing;  ﬁve
years  after  bilateral  blindness,
severe  tetraparesis,
neurogenic  bladder
Buraga28 42  years  old  female  Spinal  Urological  Yes  Multiple  sclerosis  ﬁrst
diagnosed  after  spinal
anesthesia
Berger29 53  years,  male  Spinal  Urological/plastic
surgery
No
Leigh30 43  years,  male Spinal  Laparotomy  No
Wang31 45  years,  female EA  CS  No  Preexisting  diseases:  von
Hipple  Lindau  disease
Kohler32 29  years,  female  EA  Vaginal  delivery  No
Gunaydin21 29  years,  female  EA  CS  No  Improvement  of  neurological
symptoms  postpartum
Vadalouca33 56  years,  female  CSE  Hysterectomy  No
Marshak34 61  years,  female  EA  Thoracotomy  No
Barbosa35 32  years,  female  Spinal  CS  No
Mayorga Buiza36 37  years,  female  EA  CS  No
Martucci37 29  years,  female  Spinal  CS  No
Tympa38 45  years,  female  EA  Hysterectomy  No  Other  pre-existing  disease:
ischemic  brain  infarct,
antiphospholipid  syndrome,
and -heterozygous
thalassemia
Shanmugam39 68  years,  female  EA  Oesophagectomy  No  Postoperative  improvement  of
lower  limb  mobility  and
strength
Patel40 46  years,  female  EA  Cystectomy  No  Intrathecal  baclofen  pump
implanted
Oouchi41 29  years,  female  Spinal  CS  No
Sethi42 32  years,  female  EA  CS  No
Bettencourt43 36  years,  female  EA  CS  No
esare
r
ﬁ
pEA, epidural anesthesia; CSE, combined spinal and epidural; CS, cPlease  cite  this  article  in  press  as:  Bornemann-Cimenti  H,  et  a
--  a  systematic  review.  Rev  Bras  Anestesiol.  2016.  http://dx.do
egarded  to  be  related  to  spinal  anesthesia,  resulting  in
nancial  compensation  for  the  patient.14
In  our  systematic  literature  search,  we  found  two
rospective  studies,  both  on  epidural  analgesia  in  an
o
s
w
Fan section.l.  Neuraxial  anesthesia  in  patients  with  multiple  sclerosis
i.org/10.1016/j.bjane.2016.09.001
bstetric  setting.  The  ﬁrst  was  the  PRIMS  (Pregnancy  and  MS)
tudy.  This  European  multicenter  study  followed  254  women
ith  MS  during  pregnancy  and  12  months  after  delivery.15
orty-two  parturients  had  epidural  analgesia  for  delivery.
Please  cite  this  article  in  press  as:  Bornemann-Cimenti  H,  et  al.  Neuraxial  anesthesia  in  patients  with  multiple  sclerosis
--  a  systematic  review.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016.09.001
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Table  2  Case  series  and  studies  of  patients  with  multiple  sclerosis  undergoing  neuroaxial  analgesia.
Author
(reference)
Study  type  n  Type  of
anesthesia
Type  of
surgery
Check  up  Complication  Art  der
Komplikation
Bamford44 Case  series  8  patients
12  interventions
Spinal  (9)  Vaginal
delivery,
minor
surgical
interventions
--  Yes  1  patient  with
leg  weakness
Caudal (3)
Stenuit45 Case  series  5  Spinal  CS,
urological
and
orthopedica
--  yes  MS  ﬁrst
diagnosed  after
spinal  anesthesia
in 2  patients,  1
patient  with
exacerbation  of
symptoms  for  1
year
Bouchard46 Case  series  9  patients
14  interventions
Spinal  Urological
and  plastic
surgery
--  Yes  1  patient  with
temporary
exacerbation,  no
further
description  of
symptoms
Bader47 Case  series  20  patients
32 pregnancies
EA  (14)  CS,  vaginal
delivery
3  month  Yes  5  patients  with
relapse,  no
further
description  of
symptoms
Dalmas48 Case  series  19  EA  CS,  vaginal
delivery
4  years  Yes  1  patient
developed  5
month  postnatal
retro  bulbar
neuritis  and
dysesthesia  of
the  extremities
Confavreux15 Prospective
cohort  study
(PRIMS  study)
42  EA  Vaginal
delivery,  CS
12  month  No
Kyttä49 Case  series  5  EA  (3)  Urological
and  plastic
surgery
--  No
Spinal  (2)
Vukosic16 Prospective
cohort  study
(PRIMS  Study
follow-up)
42  EA  Vaginal
delivery,  CS
2  years  No
Hebl6 Case  series  35  EA  (18)  Vaginal
delivery
mixed
surgery
46  ±  38  days  No
Spinal  (17)
May50 Case  series  5  EA  (4)  Vaginal
delivery,  CS
--  No
Spinal  (1)
Pastó17 Prospective
cohort  study
65  EA  Vaginal
delivery,  CS
6  month  No
PDA, peridural anesthesia; CS, cesarean section.
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hen  compared  to  180  parturients  with  MS  who  had  no
pidural  analgesia,  no  signiﬁcant  effect  on  relapse  rate  or
everity  of  worsening  of  disabilities  was  found.  In  the  follow-
p  analysis  2  years  later,  the  results  were  conﬁremd.16
In  2012,  Pastò  et  al.  presented  their  prospective  cohort
tudy  from  the  Italian  MS  Study  Group.17 They  collected  data
rom  the  gestational  period  until  12  months  after  delivery
rom  415  paturients  with  MS.  Although  65  patients  under-
ent  epidural  analgesia,  this  did  not  affect  the  relapse  rate
r  the  time-dependent  proﬁle  of  relapse.
This  is  the  ﬁrst  systematic  review  which  aims  to  include
ll  reported  cases  in  current  literature.  Although  all  avail-
ble  guidelines  and  recommendations  refer  to  certain  cases,
he  exact  number  was  not  yet  investigated.  We  speciﬁcally
ecided  to  include  these  cases  in  our  systematic  review  to
rovide  an  assessment  of  the  frequency  of  noticeable  post-
perative  courses.  Taking  the  high  prevalence  of  MS  between
0  and  200/100,00018 into  consideration,  the  total  number
f  reported  cases  in  which  symptoms  deteriorated  after  neu-
axial  analgesia  seems  extremely  low.  However,  this  number
ay  be  highly  biased,  as  the  majority  of  cases  are  likely
o  be  unreported.  Even  so,  worsening  of  MS  after  neuraxial
nalgesia  can  be  considered  a  rare  event.
Over  a  period  of  65  years,  our  systematic  literature
earch  resulted  in  10  patients,  in  whom  MS  was  worsened
nd  nine  in  whom  MS  or  neuromyelitis  optica  was  ﬁrst  diag-
osed  in  a  timely  context  with  central  neuraxial  analgesia.
owever,  timely  correlation  does  not  imply  causality.
The  majority  of  cases  were  described  in  obstetric  sett-
ngs.  This  can  be  explained  by  two  facts:  ﬁrst,  due  to
he  combined  effect  of  sex  and  age,  the  incidence  for
S  is  increased  in  the  obstetric  population.  Second,  in
bstetric  anesthesia  and  analgesia,  neuraxial  techniques
re  more  commonly  applied  in  patients  with  MS  compared
o  healthy  controls.19 During  pregnancy,  symptoms  of  MS
ften  improve,  whereas  postpartum  relapse  rates  have  been
hown  to  increase.15 Worsening  of  symptoms  could  there-
ore  also  be  attributed  to  the  normal  course  of  disease  after
hildbirth.
Stress  is  a  well-known  risk  factor  for  the  onset  and
elapse  of  MS.20 Therefore,  strategies  to  decrease  perioper-
tive  stress  help  to  prevent  postoperative  deterioration  of
ymptoms.  Optimizing  pain  management  by  EA  is  potentially
eneﬁcial  in  the  postoperative  course  of  MS;  in  two  cases,
re-existing  neurological  deﬁcits  improved  after  EA.21,22
In  some  clinical  recommendations,  epidural  is  preferred
o  spinal  analgesia  in  patients  with  MS.9,12 Based  on  two
ndependent  prospective  studies,  EA  in  obstetric  patients
howed  no  negative  outcome.15--17 For  spinal  anesthesia,
nly  case  reports  exist,  and  these  do  not  show  a  clear  rela-
ion  between  cause  and  effect.  The  intrathecal  application
f  higher  concentrations  of  local  anesthetics  compared  with
A  is  discussed  as  possibly  increasing  the  risk  of  relapse.6,13
owever,  there  is  neither  a  clear  hypothesis  of  the  potential
echanism  behind  this  assumption  nor  clinical  data  to  sup-
ort  this  assumption.  On  the  other  hand,  spinal  anesthesia  is
erformed  frequently  in  patients  with  MS.7 One  may  argue
hat  the  number  of  reported  cases  with  a  deteriorated  post-Please  cite  this  article  in  press  as:  Bornemann-Cimenti  H,  et  a
--  a  systematic  review.  Rev  Bras  Anestesiol.  2016.  http://dx.do
perative  course  only  reﬂects  a  marginal  risk,  if  any,  for  the
ndividual  patient.
For  CSE  and  caudal  analgesia,  we  found  only  one  and
hree  cases,  respectively.  The  low  number  is  easily  explained
1 PRESS
H.  Bornemann-Cimenti  et  al.
s  caudal  analgesia  is  a  rarely  used  technique  in  adults.23
SE,  on  the  other  hand,  is  often  omitted  as  most  patients
ith  MS  are  scheduled  for  elective  surgery  or  delivery  and
o  early  placement  of  EA  (if  any)  is  attempted.
Our  study  is  limited  as  a  systematic  review  cannot  ulti-
ately  prove  the  safety  of  a  procedure,  especially  when  the
esults  mainly  include  case  reports  and  series.  Individual
ase  cannot  prove  or  refute  a  cause  and  effect  relation-
hip.  Quantifying  the  number  of  cases,  however,  permits  the
valuation  of  the  scientiﬁc  basis  of  some  concerns.
Another  limitation  is  that  we  cannot  provide  details  on
he  material  and  medication  used  in  the  reported  cases,
s  these  information  were  not  reported  in  the  majority  of
ublications.
Future  approaches  for  elucidating  this  problem  may
nvolve  prospectively  collected,  large,  multinational
atabases  in  which  postoperative  courses  of  patients  with
S  are  collected  and  risk  factors  may  be  identiﬁed.
onclusion
n  conclusion,  it  is  impossible  to  completely  rule  out  poten-
ial  risks  from  any  procedure.  Current  clinical  evidence  does
ot  support  the  theory  that  central  neuraxial  analgesia  neg-
tively  affects  the  course  of  MS.  Therefore,  we  regard  this
rocedure  as  a  viable  option  for  discussion  with  the  patient.
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